Molecular characterization of dipeptidyl peptidase activity in serum soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides

European Journal of Biochemistry

Volumn 267, Issue 17, 2000, Pages 5608-5613

  Durinx, Christine ^a   Lambeir, Anne Marie ^a   Bosmans, Eugène ^b   Falmagne, Jean Bernard ^b   Berghmans, Raf ^b   Haemers, Achiel ^a   Scharpé, Simon ^a   De Meester, Ingrid ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b Eurogenetics   (Belgium)

Author keywords

Attractin; CD26; Dipeptidyl peptidase IV; Serum protease; Type 2 diabetes

Indexed keywords

ADENOSINE DEAMINASE; DIPEPTIDYL PEPTIDASE IV;

AFFINITY CHROMATOGRAPHY; AMINO TERMINAL SEQUENCE; ARTICLE; CIRCULAR DICHROISM; HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; SERUM; THERMOSTABILITY;

AMINO ACID SEQUENCE; ANTIGENS, CD26; CHROMATOGRAPHY, AFFINITY; CHROMATOGRAPHY, GEL; CIRCULAR DICHROISM; DIPEPTIDES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; MOLECULAR SEQUENCE DATA; PROLINE; RECOMBINANT PROTEINS; SEMEN;

EID: 0033852128     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.2000.01634.x     Document Type: Article

References (47)

1. CD26, let it cut or cut it down
2. Dipeptidyl peptidase IV: A cell surface peptidase involved in regulating T cell growth
3. Dipeptidyl-peptidase IV (CD26) - Role in the inactivation of regulatory peptides
4. Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage
5. Amino-terminal truncation of chemokines by CD26/dipeptidyl-peptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection
6. Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor lalpha (SDF-lalpha) and SDF-1beta are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage
7. Truncation of macrophage-derived chemokine by CD26/dipeptidyl-peptidase IV beyond its predicted cleavage site affects chemotactic activity and CC chemokine receptor 4 interaction
8. CD26/dipeptidyl-peptidase IV down-regulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin by affecting its interaction with CC chemokine receptor 3
9. Proteolyticprocessing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV
10. Dipeptidylpeptidase IV and trypsin-like enzymatic degradation of human growth hormone-releasing hormone in plasma
11. Kinetics of dipeptidyl peptidase IV proteolysis of growth hormone-releasing factor and analogs
12. Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1 (7-36) amide, peptide histidine methionine and is responsible for their degradation in human serum
13. Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV
14. Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IV
15. Amino-terminal truncation of procalcitonin, a marker for systemic bacterial infections, by dipeptidyl peptidase IV (DP IV)
16. Dipeptidyl peptidase IV (DPIV/CD26) degradation of glucagon. Characterization of glucagon degradation products and dpiv-resistant analogs
17. Dipeptidyl peptidase IV inhibition potentiates the insulinotropic effect of glucagon-like peptide 1 in the anesthetized pig
18. Improved glucose tolerance in Zucker fatty rats by oral administration of the dipeptidyl peptidase IV inhibitor isoleucine thiazolidide
19. Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes
20. Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26
21. The T cell triggering molecule Tp103 is associated with dipeptidyl aminopeptidase IV activity
22. A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase
23. Glycylprolyl β-naphthylamidase activity in human serum
24. Serum glycylproline p-nitroanilidase activity in rheumatoid arthritis and systemic lupus erythematosus
25. Dipeptidyl peptidase IV from human serum: Purification, characterization, and N-terminal amino acid sequence
26. Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers
27. Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts
28. Dipeptidyl-peptidase IV-beta, a novel form of cell-surface-expressed protein with dipeptidyl-peptidase IV activity
29. Dipeptidyl-peptidase IV-beta - Further characterization and comparison to dipeptidyl-peptidase IV activity of CD26
30. Activities of dipeptidyl peptidase II and dipeptidyl peptidase IV in mice with lupus erythematosus-like syndrome and in patients with lupus erythematosus and rheumatoid arthritis
31. A novel form of dipeptidylpeptidase IV found in human serum
32. Serum high molecular weight dipeptidyl peptidase IV (CD26) is similar to a novel antigen DPPT-L released from activated T cells
33. Attractin (DPPT-L), a member of the CUB family of ceil adhesion and guidance proteins, is secreted by activated human T lymphocytes and modulates immune cell interactions
34. The mahogany mouse mutation further links between pigmentation, obesity and the immune system
35. Secreted and membrane attractin result from alternative splicing of the human ATRN gene
36. Sequence, purification, and cloning of an intracellular serine protease, quiescent cell proline dipeptidase
37. Assay of dipeptidyl peptidase IV in serum by fluorometry of 4-methoxy-2-naphthylamide
38. Use of immobilized adenosine deaminase (EC 3.5.4.4) for the rapid purification of native human CD26/dipeptidyl peptidase IV (EC 3.4.14.5)
39. A prediction of DPP IV/CD26 domain structure from a physico-chemical investigation of dipeptidyl peptidase IV (CD26) from human seminal plasma
40. Structure-activity relationship of diaryl phosphonate esters as potent irreversible dipeptidyl peptidase IV inhibitors
41. Pyrrolidides: Synthesis and structure-activity relationships as inhibitors of dipeptidyl peptidase IV
42. Proteins of the kidney microvillar membrane
43. N-terminal amino-acid sequence of pig kidney dipeptidyl peptidase IV solubilized by autolysis
44. The purification, characterization and analysis of pimary and secondary-structure of prolyl oligopeptidase from human lymphocytes
45. Prolyl oligopeptidase: An unusual beta-propeller domain regulates proteolysis
46. Binding to human dipeptidyl peptidase IV by adenosinedeaminase and antibodies that inhibit ligand binding involves overlapping, discontinuous sites on a predicted beta propeller domain
47. The adenosine deaminase-binding region is distinct from major anti-CD26 mAb epitopes on the human dipeptidyl peptidase IV (CD26) molecule